Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study-Reference-Cited by-同舟云学术

Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study

Published:2020-04-01 Issue:8 Volume:31 Page:1499-1506
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Söreskog E., ,Borgström F.,Shepstone L.,Clarke S.,Cooper C.,Harvey I.,Harvey N. C.,Howe A.,Johansson H.,Marshall T.,O’Neill T. W.,Peters T. J.,Redmond N. M.,Turner D.,Holland R.,McCloskey E.,Kanis J. A.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-020-05372-6.pdf

Reference37 articles.

1. Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA, IOF, EURPo (2013) Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 8:137. https://doi.org/10.1007/s11657-013-0137-0

2. Kanis JA, Cooper C, Rizzoli R, Reginster JY, on behalf of the Scientific Advisory Board of the European Society for, C, Economic Aspects of, O, the Committees of Scientific, A, and National Societies of the International Osteoporosis, F (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3–44. https://doi.org/10.1007/s00198-018-4704-5

3. Kanis JA, Borgstrom F, Compston J, Dreinhofer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R, Stenmark J (2013) SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 8:144. https://doi.org/10.1007/s11657-013-0144-1

4. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397. https://doi.org/10.1007/s00198-007-0543-5

5. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033–1046. https://doi.org/10.1007/s00198-007-0343-y

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on fracture risk assessment in osteoporosis;Current Opinion in Endocrinology, Diabetes & Obesity;2024-05-30

2. Insights and implications of sexual dimorphism in osteoporosis;Bone Research;2024-02-18

3. Osteoporosis: Treatment gaps and health economics;Reference Module in Biomedical Sciences;2024

4. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis;Journal of Endocrinological Investigation;2023-10-24

5. Explaining declining hip fracture rates in Norway: a population-based modelling study;The Lancet Regional Health - Europe;2023-07